Paradigm Biopharmaceuticals Ltd (ASX:PAR)

APAC company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PAR

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PAR

  • Market CapAUD0.000m
  • SymbolASX:PAR
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINAU000000PAR5

Company Profile

Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company. The Company is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema.

Latest PAR news

Currently there for this company. Visit our news hub for other news .